Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harrow (HROW) Cash & Equivalents (2016 - 2025)

Harrow has reported Cash & Equivalents over the past 13 years, most recently at $72.9 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $72.9 million for Q4 2025, up 54.35% from a year ago — trailing twelve months through Dec 2025 was $72.9 million (up 54.35% YoY), and the annual figure for FY2025 was $72.9 million, up 54.35%.
  • Cash & Equivalents for Q4 2025 was $72.9 million at Harrow, down from $74.3 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for HROW hit a ceiling of $96.3 million in Q4 2022 and a floor of $6.5 million in Q1 2021.
  • Median Cash & Equivalents over the past 5 years was $61.7 million (2021), compared with a mean of $55.8 million.
  • Biggest five-year swings in Cash & Equivalents: skyrocketed 1675.99% in 2021 and later tumbled 54.11% in 2023.
  • Harrow's Cash & Equivalents stood at $42.2 million in 2021, then skyrocketed by 128.31% to $96.3 million in 2022, then decreased by 23.04% to $74.1 million in 2023, then plummeted by 36.23% to $47.2 million in 2024, then soared by 54.35% to $72.9 million in 2025.
  • The last three reported values for Cash & Equivalents were $72.9 million (Q4 2025), $74.3 million (Q3 2025), and $53.0 million (Q2 2025) per Business Quant data.